Equity Profile

ARE

Alexandria Real Estate Equities, Inc.

Real EstateHealth Care REITs$8.3B

Aug3Mon

Pre-Earnings Brief

UpcomingQ2-2026After Close5:00 PM EDT

Company Snapshot

Alexandria Real Estate Equities, Inc. (ARE) is a real estate investment trust (REIT) focused on the life sciences and technology sectors....

Key Metrics to Watch

EPS

Earnings per share is a key indicator of profitability and will show how well the company is managing its costs and generating income.

$0.12

Revenue

Total revenue provides insight into the company's overall business performance and growth trajectory.

$656M

Wall Street expectations, options signals, track record, and call prep available with Pro.

ARE Q2-2026 Earnings Preview

Context

Company Snapshot

Alexandria Real Estate Equities, Inc. (ARE) is a real estate investment trust (REIT) focused on the life sciences and technology sectors. With a market cap of $8 billion, it plays a crucial role in providing specialized real estate for research and development, which is increasingly important as health care and biotech industries grow.

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

25%

Avg EPS Surprise

-10.19%

Avg Stock Reaction

-0.85%

Last Quarter Recap

In Q1-2026, Alexandria reported an EPS of $1.73, matching analyst expectations. However, the stock fell by nearly 4% the following day, indicating market disappointment despite meeting EPS estimates.

Management Promises & Guidance

Expectations

Wall Street Expectations

Analysts expect Alexandria to report stable earnings with a consensus EPS of $0.12 and revenue of $656 million. The market is closely watching for any signs of growth or challenges in the life sciences sector.

Bull Case

If Alexandria can exceed the EPS estimate and show strong revenue growth, it may signal robust demand for its properties, leading to a positive market reaction.

Bear Case

Conversely, if the company misses earnings expectations again, it could raise concerns about its operational efficiency and market demand, potentially leading to further stock declines.

Key Metrics to Watch

EPS

$0.12

Earnings per share is a key indicator of profitability and will show how well the company is managing its costs and generating income.

Revenue

$656M

Total revenue provides insight into the company's overall business performance and growth trajectory.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will the company provide any guidance on future revenue growth in the life sciences sector?

This information is crucial as it will help investors gauge the company's growth prospects and market demand.

How does Alexandria plan to manage its operational costs moving forward?

Understanding cost management strategies will be key to assessing profitability and overall financial health.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating the potential for Alexandria to capitalize on increased demand for life sciences real estate, given recent trends in biotech investments.

Supporting Evidence

The company's previous EPS surprises indicate potential for positive revisions.

Options pricing suggests a larger move than historical averages, indicating market uncertainty.

Recent trends in biotech funding could lead to higher occupancy rates for Alexandria's properties.

Key Risk

If the company reports strong leasing activity or new partnerships, it could challenge the current bearish sentiment.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The market is debating whether Alexandria can sustain its growth in a competitive environment, particularly in the life sciences sector.

Bull Confirmed If

A revenue growth rate exceeding 5% year-over-year would confirm the bullish outlook.

Bear Confirmed If

If EPS falls below $0.12, it would reinforce bearish sentiment about the company's operational challenges.

Pre-Earnings Positioning

Options Market

Implied Move

±21.34%

Historical Avg

±1.6%

Pricing rich

The options market is pricing in a significant potential move, indicating that investors expect volatility around the earnings announcement.

Options are pricing ±21.3% while ARE has averaged ±1.6% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.4%

30d HV

52.1%

Calls (288K)P/C Ratio: 0.49Puts (1.1M)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Alexandria beats expectations, history suggests the stock could rise by around 1.64% on the first day, confirming a positive outlook.

In-Line / Cautious

If results are in line with expectations, the stock may see muted movement as investors await further guidance.

Miss

A miss could lead to a decline of approximately 0.58%, reflecting ongoing concerns about the company's performance.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Details on leasing activity and occupancy rates in the life sciences sector.
2Any updates on new property developments or acquisitions.
3Management's outlook on market demand for health care real estate.
4Insights into operational cost management strategies.
5Comments on competitive pressures in the real estate market.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

Aug3

ONBMO

ON Semiconductor Corporation

PreviewView

Aug3

LBMO

Company Snapshot

Alexandria Real Estate Equities, Inc. (ARE) is a real estate investment trust (REIT) focused on the life sciences and technology sectors....

Key Metrics to Watch

EPS

Earnings per share is a key indicator of profitability and will show how well the company is managing its costs and generating income.

$0.12

Revenue

Total revenue provides insight into the company's overall business performance and growth trajectory.

$656M

Wall Street expectations, options signals, track record, and call prep available with Pro.

ARE Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

25%

Avg EPS Surprise

-10.19%

Avg Stock Reaction

-0.85%

Last Quarter Recap

In Q1-2026, Alexandria reported an EPS of $1.73, matching analyst expectations. However, the stock fell by nearly 4% the following day, indicating market disappointment despite meeting EPS estimates.

Management Promises & Guidance

Expectations

Wall Street Expectations

Bull Case

If Alexandria can exceed the EPS estimate and show strong revenue growth, it may signal robust demand for its properties, leading to a positive market reaction.

Bear Case

Conversely, if the company misses earnings expectations again, it could raise concerns about its operational efficiency and market demand, potentially leading to further stock declines.

Key Metrics to Watch

EPS

$0.12

Earnings per share is a key indicator of profitability and will show how well the company is managing its costs and generating income.

Revenue

$656M

Total revenue provides insight into the company's overall business performance and growth trajectory.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will the company provide any guidance on future revenue growth in the life sciences sector?

This information is crucial as it will help investors gauge the company's growth prospects and market demand.

How does Alexandria plan to manage its operational costs moving forward?

Understanding cost management strategies will be key to assessing profitability and overall financial health.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating the potential for Alexandria to capitalize on increased demand for life sciences real estate, given recent trends in biotech investments.

Supporting Evidence

The company's previous EPS surprises indicate potential for positive revisions.

Options pricing suggests a larger move than historical averages, indicating market uncertainty.

Recent trends in biotech funding could lead to higher occupancy rates for Alexandria's properties.

Key Risk

If the company reports strong leasing activity or new partnerships, it could challenge the current bearish sentiment.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The market is debating whether Alexandria can sustain its growth in a competitive environment, particularly in the life sciences sector.

Bull Confirmed If

A revenue growth rate exceeding 5% year-over-year would confirm the bullish outlook.

Bear Confirmed If

If EPS falls below $0.12, it would reinforce bearish sentiment about the company's operational challenges.

Pre-Earnings Positioning

Options Market

Implied Move

±21.34%

Historical Avg

±1.6%

Pricing rich

The options market is pricing in a significant potential move, indicating that investors expect volatility around the earnings announcement.

Options are pricing ±21.3% while ARE has averaged ±1.6% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.4%

30d HV

52.1%

Calls (288K)P/C Ratio: 0.49Puts (1.1M)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Alexandria beats expectations, history suggests the stock could rise by around 1.64% on the first day, confirming a positive outlook.

In-Line / Cautious

If results are in line with expectations, the stock may see muted movement as investors await further guidance.

Miss

A miss could lead to a decline of approximately 0.58%, reflecting ongoing concerns about the company's performance.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Details on leasing activity and occupancy rates in the life sciences sector.
2Any updates on new property developments or acquisitions.
3Management's outlook on market demand for health care real estate.
4Insights into operational cost management strategies.
5Comments on competitive pressures in the real estate market.